Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus | MicrobiomeTrials
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2015-06-01Est. Completion: 2017-01-23
Enrollment target: 105 participants
Locations
Investigator Site, Anniston, Alabama, United States
Investigator Site, Clearwater, Florida, United States
Investigator Site, Minsk, Belarus
Investigator Site, Minsk, Belarus
Investigator Site, Vitebsk, Belarus
Investigator Site, Plovdiv, Bulgaria
Investigator Site, Plovdiv, Bulgaria
Investigator Site, Sofia, Bulgaria
Investigator Site, Tbilisi, Georgia
Investigator Site, Kemerovo, Russia
Investigator Site, Kursk, Russia
Investigator Site, Omsk, Russia
Investigator Site, Orenburg, Russia
Investigator Site, Smolensk, Russia
Investigator Site, Vladimir, Russia
Investigator Site, Vinnytsia, Ukraine
Investigator Site, Vinnytsia, Ukraine
Investigator Site, Zaporizhia, Ukraine
Other microbiome trials you might be interested in